The Centers for Disease Control and Prevention (CDC) is working with the National Park Service and the California Department of Public Health on an investigation of hantavirus pulmonary syndrome (HPS) in people who stayed at Yosemite National Park during June through August 2012.
On Aug. 31, the CDCÂ issued an official health advisory to inform state health departments and healthcare providers to be alert to the possibility of HPS in patients who may have had recent exposure to rodents or a history of travel to Yosemite National Park during this period.
HPS is an acute, zoonotic viral disease that is spread by contact with infected rodents, primarily deer mice. Most persons with HPS are infected by breathing in small viral particles from rodent urine or droppings that have been stirred up into the air. The fatality rate is approximately 36 percent.
Â
Since June 10, 2012, six confirmed cases of HPS have been associated with staying at Yosemite National Park in California. Two of the ill persons died. Additional suspected cases are being investigated from multiple health jurisdictions. Four case-patients with HPS stayed in Signature Tent Cabins in the Boystown area of Curry Village, and the lodging locations of the remaining 2 case-patients are currently under investigation. These cabins have solid walls on the interior of the cabin and are covered with canvas exterior sides and roof. An estimated 10,000 persons stayed in these cabins from June 10 through Aug. 24, 2012. On August 24, 2012, the tents were disinfected and visitors were relocated. People who stayed in the tents between June 10 and Aug. 24 may be at risk of developing HPS in the next six weeks. Providers are reminded to consider the diagnosis of HPS in all persons presenting with clinically compatible illnesses and to ask about potential rodent exposure or if they had recently visited Yosemite National Park.
All guests who made reservations to stay in these cabins from June 10 through Aug. 24, 2012 (approximately 2,900 persons) were emailed or mailed a health advisory urging them to seek immediate medical attention if they or other persons in their party exhibit symptoms of HPS.
The incubation period for HPS is typically two to four weeks after exposure, with a range of a few days up to six weeks. Symptoms of HPS include an initial prodrome of fever, chills, myalgias, cough, headaches, and gastrointestinal symptoms. Laboratory abnormalities in HPS include thrombocytopenia, leukocytosis, hemoconcentration, hypoalbuminemia, and an increase in serum LDH. Chest radiographs may show bilateral interstitial infiltrates. The disease often progresses rapidly to respiratory distress requiring supplemental oxygen and/or intubation, non-cardiogenic pulmonary edema, and shock. There is no specific treatment available, but early recognition and administration of supportive care greatly increase the chance of survival.
Recommendations include laboratory testing of patients with symptoms consistent with HPS is required to confirm the diagnosis. Because it is a reportable disease in the United States, clinicians suspecting HPS should notify and consult with their state health department about confirmatory testing. HPS-specific testing can be done with serum or whole blood, or with tissue samples in fatal cases.
For additional information about HPS symptoms and diagnosis, visit the CDCs Hantavirus webpage at: http://www.cdc.gov/hantavirus/technical/hps/index.html
The clinical case definition for HPS can be found on pages 39-40 in the CDC document, 2012 Nationally Notifiable Diseases and Conditions and Current Case Definitions at: http://wwwn.cdc.gov/nndss/document/2012_Case%20Definitions.pdfÂ
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.